SCHEMBL3094972

SCHEMBL3094972

CCc1nc(C2CCCCC2)c(C(N)=O)cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
CDC7 O00311 1/20 0.37
CD38 P28907 1/20 0.37
PTGS2 P35354 4/20 0.35
PTGS1 P23219 2/20 0.35
PARP10 Q53GL7 2/20 0.34
PARP15 Q460N3 1/20 0.34
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34
TYK2 P29597 1/20 0.34
JAK3 P52333 1/20 0.34
KCNJ6 P48051 1/20 0.34
KCNJ3 P48549 1/20 0.34
PDE4D Q08499 1/20 0.33
PDE7A Q13946 1/20 0.33
DGAT1 O75907 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4329258 0.78 MAPT (0.42) KDM4EMEN1MAPTKMT2ACDC7
SCHEMBL29580982 0.77 PARP1 (0.43) KDM4EMEN1MAPTKMT2ACDC7
SCHEMBL9695834 0.74 EEF2K (0.44) KDM4EALDH1A1PARP1
SCHEMBL27566354 0.73 CSNK1D (0.48) KDM4EALDH1A1CSNK1D
SCHEMBL31171355 0.72 KDM4E (0.42) KDM4EMEN1MAPTKMT2ACDC7
SCHEMBL19121329 0.68 TRPV1 (0.39) KDM4EMEN1MAPTKMT2ACDC7
SCHEMBL3602173 0.66 F2 (0.36) KDM4EMEN1MAPTKMT2ACDC7
SCHEMBL30830272 0.66 CSNK1D (0.44) KDM4EALDH1A1CSNK1D
SCHEMBL26984655 0.66 CSNK1D (0.44) KDM4EALDH1A1CSNK1D
SCHEMBL4153908 0.65 NNMT (0.47) KDM4EMEN1MAPTKMT2ACDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173888-A1 Nicotinamide Derivatives PFIZER INC 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173888-A1 Nicotinamide Derivatives NNT, NAMPT, NQO1 KDM4E 3753/4885MEN1 2257/4885MAPT 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.